Fig. 3
Evolution of selected analytical parameters during the first 6 months after imatinib discontinuation. *Changes in all the parameters were statistically significant (P < 0.001) by the Skillings–Mack test
Fig. 3 | Blood Cancer Journal
Evolution of selected analytical parameters during the first 6 months after imatinib discontinuation. *Changes in all the parameters were statistically significant (P < 0.001) by the Skillings–Mack test
